NCT Number: NCT01000558
SWOG-8947 Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
RATIONALE: Collecting and storing samples of blood from patients with cancer to test in the laboratory may help the study of cancer in the future.
PURPOSE: This research study is collecting and storing blood samples from patients with previously untreated non-Hodgkin lymphoma.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Observational
Primary location
Providence Cancer Center at Providence Hospital, Mobile, Alabama, United States
About this study
OBJECTIVES:
- To establish a central lymphoma serum repository that will serve as a resource to provide specimens for current and future scientific studies.
- To utilize the Southwest Oncology Group clinical database to perform clinicopathologic correlations with the results of those studies.
OUTLINE: Serum is collected and stored for future correlative studies.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
DISEASE CHARACTERISTICS:
- Diagnosis of non-Hodgkin lymphoma
- Previously untreated disease
- Patients must meet the eligibility criteria and be registered to a currently active Southwest Oncology Group-coordinated treatment protocol for previously untreated non-Hodgkin lymphoma
PATIENT CHARACTERISTICS:
- Not specified
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Treatment and study plan
Primary outcomes
-
Establishment of a Centralized Lymphoma Serum Repository for the Southwest Oncology Group
Time frame: July 2011
Sponsors and collaborators
Lead sponsor
SWOG Cancer Research Network
Network
Collaborators
- National Cancer Institute (NCI)
Registry information
Official study title
Central Lymphoma Serum Repository Protocol
Important dates
- Study start
- 2005
- Primary completion
- 2011
- Study completion
- 2011
- First posted
- Oct 23, 2009
- Registry last updated
- May 20, 2013
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression
NCT03480360
Acute Myeloid Leukemia, Anemia
Lebanon, New Hampshire, United States
View Trial DetailsCarmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma
NCT00641381
Burkitt Lymphoma, DNA Virus Infections
Duarte, California, United States
View Trial DetailsStudy of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies
NCT05371054
Hematologic Diseases, Hematologic Malignancies
Bethesda, Maryland, United States
View Trial DetailsResiliency in Older Adults Undergoing Bone Marrow Transplant
NCT04188678
Acute Myelogenous Leukemia, Blood Cancer
Baltimore, Maryland, United States
View Trial Details